AAP
PLSE icon

Arax Advisory Partners’s Pulse Biosciences PLSE Stock Holding History

Arax Advisory Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Buy
1,020
+767
+303% +$18.1K ﹤0.01% 3714
2026
Q1 		$5.46K Buy
253
+9
+4% +$166 ﹤0.01% 2737
2025
Q4 		$3.35K Sell
244
-81
-25% -$1.26K ﹤0.01% 3049
2025
Q3 		$5.75K Buy
+325
New +$5.14K ﹤0.01% 2827
2025
Q1 		– Sell
-278
Closed -$4.84K – 2957
2024
Q4 		$4.84K Buy
278
+34
+14% +$599 ﹤0.01% 1753
2024
Q3 		$4.28K Hold
244
– – ﹤0.01% 1784
2024
Q2 		$2.73K Buy
+244
New +$2.3K ﹤0.01% 1846

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Arax Advisory Partners's PLSE Position: Q2 2026 in Review

Arax Advisory Partners increased its Pulse Biosciences (PLSE) stake by 303% in Q2 2026, buying an estimated $18.1K and bringing the position to 1,020 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3714.

Arax Advisory Partners first reported a position in PLSE in Q2 2024 and has held it in 7 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Arax Advisory Partners held 1,020 shares of Pulse Biosciences worth $28.3K as of Q2 2026.
  • Arax Advisory Partners bought 767 Pulse Biosciences shares in Q2 2026, an estimated $18.1K.
  • Pulse Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3714 holding.
  • Arax Advisory Partners first reported a position in Pulse Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.